Carregant...
Oral anticoagulation in high risk Takotsubo syndrome: when should it be considered and when not?
Standard pharmacological therapy in Takotsubo syndrome (TTS) is still debated and there is a lack of prospective data. In their recent work in BMC Cardiovascular Disorders Abanador-Kamper et al. found that stroke in TTS has an event rate of 2.8% after 30 days and 4.2% after 12 months and they questi...
Guardat en:
| Publicat a: | BMC Cardiovasc Disord |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6206855/ https://ncbi.nlm.nih.gov/pubmed/30373518 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-018-0930-1 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|